1 Clinically Speaking: Conditions Treated in the Outpatient Setting Sharme Brodie, RN, CCDS CDI Educational Instructor HCPro/Simplify Compliance Middleton, MA 2 Learning Objectives • At the completion of this educational activity, the learner will be able to: – Identify common conditions treated in the outpatient setting – Describe common signs and symptoms seen in these conditions – Identify and discuss laboratory testing used to diagnose or monitor these conditions – Define documentation needed for appropriate code assignment 2019 Copyright, HCPro, a division of Simplify Compliance LLC. All rights reserved. These materials may not be copied without written permission.
24
Embed
D1 PPT 9 2019 ACDIS Outpatient CDI PPT Sharme Brodie Final 9_2019 OPCDI Symp_CDI... · there are any complications such as an exacerbation or status asthmaticus 20 Asthma (cont.)
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
1
Clinically Speaking: Conditions Treated in the Outpatient Setting
Sharme Brodie, RN, CCDSCDI Educational InstructorHCPro/Simplify ComplianceMiddleton, MA
2
Learning Objectives
• At the completion of this educational activity, the learner will be able to:
– Identify common conditions treated in the outpatient setting
– Describe common signs and symptoms seen in these conditions
– Identify and discuss laboratory testing used to diagnose or monitor these conditions
– Define documentation needed for appropriate code assignment
2019 Copyright, HCPro, a division of Simplify Compliance LLC. All rights reserved. These materials may not be copied without written permission.
3
Types of Diabetes: Causes Vary by Type
• DM 1 (E10.‐): Patient’s pancreas produces little or no insulin—unknown cause.
• DM 2 (E11.‐): Patient’s body doesn’t produce enough insulin or doesn’t use it properly. Hallmark insulin resistance—unknown cause of insulin resistance.
• Latent autoimmune/DM 1.5 (E13.‐): Characteristics of both DM 1 and 2.
• Secondary DM: Caused by another condition.
• Gestational DM (O24.410): Hormones produced during pregnancy make cells more resistant to insulin.
• Coding will depend on type of diabetes and whether there is an assumed relationship between the DM and complication; if not, physician will need to document a cause and effect relationship using appropriate verbiage such as “due to.”
• Neuropathy: Nerve damage, tingling and numbness, burning or pain caused by damage to the blood vessels related to excess sugar. Can lead to diabetic foot ulcers.
• Nephropathy: Diabetes can cause damage to glomeruli, which could lead to kidney failure or end‐stage kidney disease. May require dialysis or kidney transplant.
• Retinopathy: Damage to blood vessels of the retina; can lead to blindness, cataracts, and glaucoma.
• Skin conditions (including bacterial or fungal).
• Hearing problems (more common in people with DM).
2019 Copyright, HCPro, a division of Simplify Compliance LLC. All rights reserved. These materials may not be copied without written permission.
vegetables, whole grains– Legumes—beans and peas– Decreased alcohol consumption– Insulin (on next slide)
2019 Copyright, HCPro, a division of Simplify Compliance LLC. All rights reserved. These materials may not be copied without written permission.
7
Diabetes (cont.)
Insulin Type Brand Name Onset Peak Duration
Rapid‐acting HumalogNovologApidra
10–30 mins 30 mins–3 hours
3–5 hours
Short‐acting Regular (R) 30 mins–1 hour
2–5 hours Up to 12 hours
Intermediate‐acting
NPH (N) 1.5–4 hours 4–12 hours Up to 24 hours
Long‐acting LantusLevemir
0.8–4 hours Minimal peak Up to 24 hours
8
Obesity (E66.0) vs. Morbid Obesity (E66.01)
Obesity:
• Occurs when a person’s body mass index (BMI) is 30 or greater.
• According to the National Institutes of Health (NIH), a person is considered “obese” when weighing 20% or more than his or her ideal body weight. At that point, the person's weight poses a health risk.
• Obesity becomes “morbid” or “clinically severe” when it significantly increases the risk of one or more obesity‐related health conditions or serious diseases (comorbidities).
• Coding will depend on the physician’s documentation of obesity versus morbid obesity along with the corresponding appropriate BMI.
2019 Copyright, HCPro, a division of Simplify Compliance LLC. All rights reserved. These materials may not be copied without written permission.
9
Obesity/Morbid Obesity (cont.)
Morbid (severe) obesity can be defined as:
BMI 40+ OR
BMI 35+ and at least 2 weight‐related comorbid conditions (diabetes, hypertension, etc.)
Must document relationship of weight to comorbid conditions
Use cause‐and‐effect language if relationship is not an assumed relationship (i.e., due to, related to)
• Weight may come from muscle, bone, fat, and/or body water
10
Obesity/Morbid Obesity (cont.)
• Health problems related to overweight/obesity/morbid obesity
– Type 2 DM
– High blood pressure (HTN)
– Heart disease
– Stroke
– Cancer
– Sleep apnea
– Osteoarthritis
– Fatty liver disease
– Kidney disease
2019 Copyright, HCPro, a division of Simplify Compliance LLC. All rights reserved. These materials may not be copied without written permission.
• Hypertensive nephropathy—damages arteries around kidneys, resulting in decreased blood to kidneys
• CKD—due to effects of HTN on kidneys
Coding requires the type of HTN along with any manifestations related to the HTN. ICD‐10 uses combination codes for HTN and related manifestations.
2019 Copyright, HCPro, a division of Simplify Compliance LLC. All rights reserved. These materials may not be copied without written permission.
25
Hypertension (cont.)
Common comorbidities/complications:
• Diabetes mellitus—too much insulin causes increase in blood pressure
• Obesity—increase in weight causes increase in work on the heart
• Hyperlipidemia—cause unknown
• Anxiety/depression—caused by heart disease related to hypertension
• Sexual problems—damage to arteries, erectile dysfunction
• Bone loss/osteoporosis—HTN causes lose of calcium, which reduces bone mass
• Hypertensive retinopathy—damage to retina
26
Hypertension (cont.)
Treatment:
• Diet
• Thiazide diuretics
• Angiotensin‐converting enzyme (ACE) inhibitors
• Angiotensin II receptor blockers (ARBs)
• Calcium channel blockers
• Alpha‐blockers
• Alpha‐beta blockers
• Beta‐blockers
• Aldosterone antagonists
• Renin inhibitors
• Vasodilators
• Central‐acting agents
• Dietary supplements
2019 Copyright, HCPro, a division of Simplify Compliance LLC. All rights reserved. These materials may not be copied without written permission.
27
Cardiomyopathy (I42.‐)
There are many types of cardiomyopathy, with different causes:
• Hypertrophic cardiomyopathy (HCM) (I42.1):
– A condition in which the heart muscle becomes thick, making it harder for blood to leave the heart. This type of cardiomyopathy is usually inherited.
• Restrictive cardiomyopathy (RCM) (I42.5):
– A condition in which the walls of the heart are rigid, but not thickened, not allowing the heart to stretch and fill properly (least common type).
28
Cardiomyopathy (cont.)
• Dilated or congestive cardiomyopathy (I42.0):
– A condition in which the heart becomes weak and the chambers get large.
– Characterized by ventricular dilation, contractile dysfunction, and symptoms of CHF. As a result, the heart cannot pump enough blood out to the body.
– Inherited in one‐third of cases.
– May result from alcohol, heavy metals, CAD, cocaine use, and viral infections.
Coding requires the documentation of the type of cardiomyopathy.
2019 Copyright, HCPro, a division of Simplify Compliance LLC. All rights reserved. These materials may not be copied without written permission.
29
Cardiomyopathy (cont.)
Signs and symptoms:
• Fatigue
• Swelling
• SOB
• Arrhythmia
• Chest pain
• Heart murmurs
• Fainting/dizziness
Tests:
• BNP—blood test
• EKG
• Echocardiogram (ECHO)
• Transesophageal echo (TEE)
• Stress test
• Cardiac catherization
• Coronary angiography
• Myocardial biopsy
• Genetic testing
30
Cardiomyopathy (cont.)
Treatment: (depends on type)
• Medication
• Iatrogenic/implanted pacemakers– For slow heart rates
• Defibrillators– For patients with fatal heart rhythms
• Ventricular assist devices (VADs)– For severe heart failure
• Ablation– For recurring dysrhythmias that cannot be eliminated with medication or mechanical
cardioversion
• Heart transplant
2019 Copyright, HCPro, a division of Simplify Compliance LLC. All rights reserved. These materials may not be copied without written permission.
31
Crohn’s Disease (K50.‐)
• Type of inflammatory bowel disease (IBD)• Appears to be an autoimmune disease• Can affect any part of the gastrointestinal tract (usual onset 15–30 years of age)• Tobacco users are 2x more likely to develop than non‐smokers• Complications include:
– Ulcers– Fistulas– Anal fissure– Malnutrition– Colon cancer
ICD‐10 uses multiple combination codes that represent the diagnosis of Crohn’s disease and associated complications. Physicians must use cause‐and‐effect language if association is not assumed in code set.
32
Crohn’s Disease (cont.)
Signs and symptoms:
• Abdominal pain
• Steatorrhea
• Fecal incontinence
• Rectal tenesmus
• Fever
• Weight loss
• Cobblestone‐like appearance
Tests:
• Traditional colonoscopy with biopsy
• Capsule endoscopy
• CT scan/MRI
• Upper GI series or contrast radiography of upper GI tract
• Blood work
• Erythrocyte sedimentation rate (ESR)
2019 Copyright, HCPro, a division of Simplify Compliance LLC. All rights reserved. These materials may not be copied without written permission.
33
Crohn’s Disease (cont.)
Treatment:• Medications—corticosteroids, oral 5‐aminosalicylates, immune system
• Disease in which abnormal cells divide uncontrollably and destroy body tissue
• Can develop anywhere in the body with potential to spread and invade other areas of the body (metastasis)
• Coding varies based on location (including overlapping), behavior of cancer, and gender of patient
• Symptoms vary depending on type—over 100 types
• Histology
– Benign
– In situ
– Malignant
– Uncertain behavior
2019 Copyright, HCPro, a division of Simplify Compliance LLC. All rights reserved. These materials may not be copied without written permission.
43
Cancer (cont.)
Signs and symptoms:
• The presence of an unusual lump
• Changes in a mole on the skin
• Unexplained rash
• A persistent cough or hoarseness
• A change in bowel habits
• Abnormal bleeding
• Difficulty passing urine
• Unexplained weight loss, pain, fatigue, night sweats
• A persistent sore or ulcer
• Difficulty in swallowing or continuing indigestion
44
TNM Cancer Staging
• The TNM system is one of the most widely used staging systems to describe neoplasms. The TNM system is based on:
– T: The extent of the tumor
– N: The extent of spread to the lymph nodes
– M: The presence of distant metastasis
– A number is added to each letter to indicate the size or extent of the primary tumor and the extent of cancer spread
2019 Copyright, HCPro, a division of Simplify Compliance LLC. All rights reserved. These materials may not be copied without written permission.
45
TNM Cancer Staging (cont.)
Primary Tumor (T)
TX Primary tumor cannot be evaluated
T0 No evidence of primary tumor
Tis Carcinoma in situ (CIS; abnormal cells are present but have not spread to neighboring tissue; although not cancer, CIS may become cancer and is sometimes called pre‐invasive cancer)
T1, T2, T3, T4 Size and/or extent of the primary tumor
46
TNM Cancer Staging (cont.)
Regional Lymph Nodes
NX Regional lymph nodes cannot be evaluated
N0 No regional lymph node involvement
N1, N2, N3 Involvement of regional lymph nodes (number of lymph nodes and/or extent of spread)
Distant Metastases (M)
MX Distant metastasis cannot be evaluated
M0 No distant metastasis
M1 Distant metastasis is present
2019 Copyright, HCPro, a division of Simplify Compliance LLC. All rights reserved. These materials may not be copied without written permission.
47
National Cancer Institute Cancer Staging
For many cancers, TNM combinations correspond to one of five stages. Criteria for stages differ between types of cancer.
Stage Definition
Stage 0 Carcinoma in situ
Stage I, Stage II, and Stage III Higher numbers indicate more extensive disease: larger tumor size and/or spread of the cancer beyond the organ in which it first developed to nearby lymph nodes and/or organs adjacent to the location of the primary tumor
Stage IV The cancer has spread to another organ(s)
In order to receive your continuing education certificate(s) for this program, you must complete the online evaluation. The link can be found in the continuing education section of the program guide.
2019 Copyright, HCPro, a division of Simplify Compliance LLC. All rights reserved. These materials may not be copied without written permission.